|Mr. Martin A. Sumichrast||Chairman & Co-CEO||441k||N/A||1967|
|Mr. Raymond Scott Coffman||Co-Founder, Pres, Co-CEO & Director||186.92k||N/A||1962|
|Mr. T. Ronan Kennedy||CFO, COO, Sec. & Treasurer||N/A||N/A||1980|
|Mr. John Weston||Director of Investor Relations||N/A||N/A||N/A|
|Mr. Lance Blundell||Gen. Counsel||N/A||N/A||N/A|
|Mr. Francisco Mangual||Sr. VP of Sales||N/A||N/A||N/A|
|Mr. John J. Wiesehan III||Chief Revenue Officer||N/A||N/A||1984|
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. It owns and operates consumer hemp-based CBD brands, such as cbdMD and Paw CBD. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. The company also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name. It distributes its products through its e-commerce Website, third party e-commerce sites, wholesalers, and various brick and mortar retailers in the United States. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was founded in 2015 and is headquartered in Charlotte, North Carolina.
cbdMD, Inc.’s ISS governance QualityScore as of 1 July 2021 is 7. The pillar scores are Audit: 10; Board: 9; Shareholder rights: 1; Compensation: 8.